Suwannee, GA - June 17, 2020 - Millions of Americans are still not back at work, schools and daycares are closed, sports are on hold and concerts are all cancelled. Life as Americans know it has ground to a halt. While preventative measures such as handwashing and social distancing are helping to curb the spread of diseases, a new partnership between Level 44 Holdings and BGI Global Genomic Services aims to being reassurance to the American public.
The partnership between Level 44, a well-established women minority-owned American company with ties to the transportation and real estate market in Georgia, and BGI Global Genomic Services, A China-based medical testing company with a long history of making rapid response testing equipment, will bring affordable, non-invasive rapid medical testing to the American market. Level 44’s partnership with BGI was made possible because of assistance from Dr. Michael Savignano, Fifi Chen, ESQ, Gary Huggins, and Jay Whitley.
While providing rapid medical testing and confirmation of presumed illness are of utmost importance to the medical and business community, BGI’s testing protocols also stand out for another reason, they are primarily designed to be non-invasive. While other medical tests require blood draws in order to confirm diagnosis, BGI Global Genomic Services, specializes in the creation of medical tests which do not require blood draws. Many of BGI Global Genomic Services tests require only a simple and painless throat swab which can be conducted anywhere in the United States.
While rapid testing, which produces results within 15 minutes exists, the tests often requires a blood sample. Deploying such testing protocols in schools, offices and sporting facilities is invasive, requires extensively trained medical personnel to draw blood, presents significant challenges and is costlier than many of BGI’s tests. Furthermore, blood-based testing is only accurate 93.33 - 96.7% of the time. Less accurate than BGI tests, which are accurate 98.8% of the time. Blood-based test are also known to produce false-negatives.
“While the use of protective equipment, social distancing and hand sanitizers helps to prevent the spread of diseases, the only way to be truly confident that we, our friends, family and neighbors aren’t ill is with confirmed testing,” explains Sheneva Whitley, CEO of Level 44. “As the CDC and WHO have stated, there is a significant portion of the population that can be asymptomatic but still capable of spreading illnesses. Tests offered by BGI Global Genomic Services can help to confirm diagnosis.”
BGI rapid diagnosis tests use a throat swab rather than a more invasive, uncomfortable and less accurate nasal swab or blood test. As a result, tests can be conducted almost anywhere and are processed through Quest Diagnostics labs, which are available throughout the United States, in as little as three hours.
For more information about obtaining the rapid testing for your public institution, sports team or business, please contact Jay Whitley, Sales President.
Media Contact
Company Name: Level 44 Holdings inc
Contact Person: Jay Whitley
Email:Send Email
Phone: (770) 885 - 8582
Country: United States
Website: www.level44holdingsinc.com
